Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination.

Buil, Jochem B; Schouten, Jeroen A; Wauters, Joost; van de Hoeven, Hans; Verweij, Paul E

Buil, Jochem B; Schouten, Jeroen A; Wauters, Joost; van de Hoeven, Hans; Verweij, Paul E.

Buil JB; Department of Medical Microbiology, Radboud University Medical Center, PO box 9101, 6500 HB, Nijmegen, The Netherlands. Jochem.buil@radboudumc.nl.
Schouten JA; Center of Expertise for Mycology, Radboudumc-CWZ, Nijmegen, The Netherlands. Jochem.buil@radboudumc.nl.
Wauters J; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands. Jochem.buil@radboudumc.nl.
van de Hoeven H; Center of Expertise for Mycology, Radboudumc-CWZ, Nijmegen, The Netherlands.
Verweij PE; Radboudumc Center for Infectious Diseases, Nijmegen, The Netherlands.

Intensive Care Med ; 48(5): 611-612, 2022 05.

Article in English | MEDLINE | ID: covidwho-1750675

Subject(s)

COVID-19; Candidemia; Anti-Bacterial Agents/therapeutic use; Candidemia/drug therapy; Critical Illness/therapy; Decontamination; Digestive System; Gastrointestinal Tract; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Candidemia / COVID-19 Limits: Humans Language: English Journal: Intensive Care Med Year: 2022 Document Type: Article Affiliation country: S00134-022-06651-y

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google